# REstart or STop Antithrombotic Randomised Trial in France

> **NCT02966119** · PHASE3 · TERMINATED · sponsor: **University Hospital, Lille** · enrollment: 23 (actual)

## Conditions studied

- Cerebral Hemorrhage

## Interventions

- **DRUG:** Clopidogrel or Aspirin and/or Dypyridamole

## Key facts

- **NCT ID:** NCT02966119
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-12-07
- **Primary completion:** 2019-12-07
- **Final completion:** 2019-12-07
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** Recruitment difficulties
- **Last updated:** 2022-05-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02966119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02966119, "REstart or STop Antithrombotic Randomised Trial in France". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02966119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*